Nitroglycerin enhances cGMP expression in specific neuronal and cerebrovascular structures of the rat brain

Journal of Chemical Neuroanatomy

Volumn 27, Issue 1, 2004, Pages 23-32

  Tassorelli, C ^a   Blandini, F ^a   Greco, R ^a   Nappi, G ^a,b  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cortical arterioles; Migraine; Neurovascular coupling; Nitric oxide; Nucleus trigeminalis caudalis

Indexed keywords

CYCLIC GMP; GLYCERYL TRINITRATE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BRAIN; BRAIN BLOOD VESSEL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; IMMUNOREACTIVITY; MALE; MEDIATOR RELEASE; MIGRAINE; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION; TRIGEMINAL NUCLEUS;

EID: 1242269881     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2003.08.006     Document Type: Article

References (49)

1. Aley K.O., McCarter G., Levine J.D. Nitric oxide signaling in pain and nociceptor sensitization in the rat. J. Neurosci. 18:1998;7008-7014.
2. Berkelmans H.S., Schipper J., Hudson L., Steinbusch H.W.M., de Vente J. cGMP immunohistochemistry in aorta, kidney, retina and brain tissues of the rats after perfusion with nitroprusside. Histochemistry. 93:1989;143-148.
3. Bolay H., Reuter U., Dunn A.K., Huang Z., Boas D.A., Moskowitz M.A. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat. Med. 8:2002;136-142.
4. Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain. 89:2001;107-110.
5. Cholet N., Seylaz J., Lacombe P., Bonvento G. Local uncoupling of the cerebrovascular and metabolic responses to somatosensory stimulation after neuronal nitric oxide synthase inhibition. J. Cerebr. Blood Flow Metabol. 17:1997;1191-1201.
6. Dalsgaard-Nielsen T. Migraine diagnostics with special references to pharmacological tests. Int. Arch. Allergy Immunol. 7:1955;312-322.
7. de Vente J., Schipper J., Steinbusch H.W.M. Formaldehyde fixation of cGMP in distinct cellular pools and their recognition by different cGMP antisera: an immunocytochemical study into the problem of serum specificity. Histochemistry. 91:1996a;401-412.
8. de Vente, J., Young, HM., Steinbusch, H.W.M., 1996b. Immunoistochemical visualization of cyclic nucleotides. In: Maines, M.D. (Ed.), Nitric oxide: Characterization and Functional Analysis. Academic Press, Amsterdam, pp. 68-79.
9. de Vente, J., Steinbusch, H.W.M., 1997. cGMP-immunohistrochemistry. In: Rayne, R.C. (Ed.), Methods in Molecular Biology, vol. 72. Humana Press Inc., Totowa, pp. 125-144.
10. de Vente J., Hopkins D.A., Markerink-van Ittersum M., Emson P.C., Schmidt H.H.H.W., Steinbusch H.W.M. Distribuition of nitric oxide synthase and nitric oxide-receptive cGMP-producing structures in the rat brain. Neuroscience. 87:1998;207-241.
11. de Vente, J., Steinbusch, H.W.M., 1999. Immunocytochemical analysis of cyclic nucleotides. In: Maines, M. (Ed.), Current Protocols in Neurotoxicology Wiley and Sons Inc., Hoboken, pp.10.7.1-10.7.17.
12. de Vente, J., Steinbusch, H.W.M., 2000. Nitric oxide and cGMP signalling in the rat brain. In: Steinbusch, H.W.M., de Vente, J., Vincent S.R. (Eds.), Handbook of Chemical Neuroanatomy, vol. 17. Elsevier, Amsterdam, pp. 355-415.
13. Dirnagl U., Lindauer U., Villringer A. Role of nitric oxide in the coupling of cerebral blood flow to neuronal activation in rats. Neurosci. Lett. 149:1993;43-46.
14. Farad F.M., Breese K.R. Nitric oxide mediates vasodilatation in response to activation of N-methyl-D-aspartate receptors in brain. Circ. Res. 72:1993;476-480.
15. Ferreira J., Santos A.R., Calixto J.B. The role of systemic, spinal and supraspinal L-arginine-nitric oxide-cGMP pathway in thermal hyperalgesia caused by intrathecal injection of glutamate in mice. Neuropharmacology. 38:1999;835-842.
16. Goadsby P.J., Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann. Neurol. 33:1993;48-56.
17. Ignarro L.J. Endothelium-derived nitric oxide: pharmacology and relationship to the actions of organic nitrate esters. Pharmacol. Res. 6:1989;651-659.
18. Iversen H.K., Olesen J. Nitroglycerin-induced headache is not dependent on histamine release: support for a direct nociceptive action of nitric oxide. Cephalalgia. 14:1994;437-442.
19. Lambert G.A., Donaldson C., Boers P.M. Activation of trigeminovascular neurons by glyceryl trinitrate. Brain Res. 887:2000;203-210.
20. Lassen L.H., Ashina M., Christiansen I., Ulrich V., Olesen J. Nitric oxide synthase inhibition in migraine. Lancet. 49:1997;401-402.
21. Lindauer, U., Megow, D., Matsuda, H., Dirnagl, U. (1999). Nitric oxide a modulator, but not a mediator, of neurovascular coupling in rat somatosensory cortex. Heart Circ. Physiol. 277, H799-H811.
22. May A., Goadsby P.J. The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J. Cereb. Blood Flow Metabol. 19:1999;115-127.
23. Meller S.T., Gebhart G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain. 52:1993;127-136.
24. Moskowitz M.A., Macfarlane R. Neurovascular and molecular mechanisms in migraine headaches. Cerebrovasc. Brain Metabol. Rev. 5:1993;159-177.
25. Olesen J., Jansen-Olesen I. Nitric oxide mechanisms in migraine. Pathol. Biol. 48:2000;648-657.
26. Pardutz A., Krizbai I., Multon S., Vecsei L., Schoenen J. Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis. Neuroreport. 11:2000;3071-3075.
27. Rauch M., Schmid H.A., deVente J., Simon E. Electrophysiological and immunocytochemical evidence for a cGMP-mediated inhibition of subfornical organ neurons by nitric oxide. J. Neurosci. 17:1997;363-371.
28. Reuter U., Chiarugi A., Bolay H., Moskowitz M.A. Nuclear factor-kB as a molecular target for migraine therapy. Ann. Neurol. 51:2002;507-516.
29. Sarchielli P., Alberti A., Russo S., Codini M., Panico R., Floridi A., Gallai V. Nitric oxide pathways, Ca2+, and serotonin contents in platelets from patients suffering from chronic daily headache. Cephalalgia. 19:1999;810-816.
30. Sances, G., Tassorelli, C., Pucci, E., Ghiotto, N., Mandrini, G., Nappi, G. Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular hedaches. Cephalalgia, in press.
31. Shimomura T., Murakami F., Kotani K., Ikawa S., Kono S. Platelet nitric oxide metabolites in migraine. Cephalalgia. 19:1999;218-222.
32. Sicuteri F., del Bene E.D., Poggioni M., Bonnazzi A. Unmasking latent dysnociception in healthy subjects. Headache. 27:1987;180-185.
33. Srikiatkhachorn A., Suwattanasophon C., Ruangpattanatawee U., Phansuwan-Pujito P. 5-HT2A receptor activation and nitric oxide synthesis: a possible mechanism determining migraine attacks. Headache. 42:2002;566-574.
34. Steinbusch, H.W.M., de Vente, J., Vincent, S.R. (2000) Functional neuroanatomy of the nitric oxide system. In: Handbook of Chemical Neuroanatomy, vol. 17. Elsevier, Amsterdam, pp. 1-454.
35. Stepien A., Chalimoniuk M. Level of nitric oxide-dependent cGMP in patients with migraine. Cephalalgia. 18:1998;631-634.
36. Strosznajder J., Chalimoniuk M., Samochocki M. Activation of serotonergic 5HT1A receptors reduces Ca2+ and glutamatergic receptor-evoked arachidonic acid and NO/cGMP release in adult hippocampus. Neurochem. Int. 28:1996;439-444.
37. Tassorelli C., Greco R., Morocutti A., Costa A., Nappi G. Nitric oxide-induced neuronal activation in the central nervous system as an animal model of migraine: mechanisms and mediators. Funct. Neurol. 16(Suppl 4):2001;69-76.
38. Tassorelli C., Joseph S.A. NADPH-diaphorase activity and Fos expression in brain nuclei following nitroglycerin administration. Brain Res. 695:1995a;37-44.
39. Tassorelli C., Joseph S.A. Systemic nitroglycerin induces Fos immunoreactivity in brainstem and forebrain structures of the rat. Brain Res. 682:1995b;167-178.
40. Tassorelli C., Joseph S.A. Systemic nitroglycerin activates peptidergic and catecholaminergic pathways in rat brain. Peptides. 17:1996;443-449.
41. Tassorelli C., Joseph S.A., Nappi G. Neurochemical mechanisms of nitroglycerin-induced neuronal activation in rat brain: a pharmacological investigation. Neuropharmacology. 10:1997;1417-1424.
42. Tassorelli C., Joseph S.A., Buzzi M.G., Nappi G. The effect on the central nervous system of nitroglycerin - putative mechanisms and mediators. Prog. Neurobiol. 57:1999;607-624.
43. Tassorelli C., Blandini F., Costa A., Preza E., Nappi G. Nitroglycerin-induced activation of monoaminergic transmission in the rat. Cephalalgia. 22:2002;226-232.
44. Tassorelli C., Greco R., Dechun W., Sandrini M., Sandrini G., Nappi G. Nitroglycerin induces hyperalgesia in rats - a time course. Eur. J. Pharmacol. 464:2003;159-162.
45. Thomsen L.L., Olesen J. A pivotal role of nitric oxide in migraine pain. Ann. N.Y. Acad. Sci. 835:1997;363-372.
46. Tao Y.X., Hassan A., Haddad E., Johns R.A. Expression and action of cyclic GMP-dependent protein kinase Ialpha in inflammatory hyperalgesia in rat spinal cord. Neuroscience. 95:2000;525-533.
47. Torfgard K., Ahnler J., Axelsson K.L., Norlander B., Bertler A. Tissue distribution of glyceryl trinitrate and the effect on cGMP levels in rat. Pharmacol. Toxicol. 64:1989;369-372.
48. Wei E.P., Moskowitz M.A., Boccalini P., Kontos H.A. Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arteries. Circ. Res. 70:1992;1313-1319.
49. Xu Z.Q., de Vente J., Steinbusch H., Grillner S., Hokfelt T. The NO-cGMP pathway in the rat locus coeruleus: electrophysiological, immunohistochemical and in situ hybridization studies. Eur. J. Neurosci. 10:1998;3508-3516.